Hims & Hers Health, Inc. (HIMS)

AI-powered earnings prediction for Hims & Hers Health, Inc. (HIMS).

19.50
-4.08%
USD, 1 day ago
Market Cap
4.40B
Google

Company Overview

Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Phone
415 851 0195
Headquarters
2269 Chestnut Street
San Francisco, CA, 94123
United States
Full-Time Employees
2,442

Key Metrics

P/E Ratio (TTM)
37.83
Forward P/E
11.67
Price to Book
8.11
Beta
2.32
Profit Margin
5.47%
Gross Margin
73.83%
Return on Equity
25.23%
Return on Assets
5.29%
Earnings Growth
-17.40%
Revenue Growth
28.40%

Financial Health

Total Cash
$577.49M
Total Debt
$1.12B
Debt to Equity
207.16
Current Ratio
1.90
Free Cash Flow
$110.51M
Operating Cash Flow
$300.01M

Analyst Recommendations

Target Price (Mean)
$24.15
Target High
$30.00
Target Low
$16.00
Recommendation
hold
Analyst Coverage
13 Analysts

Trading Ideas

Related Stocks